The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis
Open accessAbstract
BACKGROUND: Proton-pump inhibitors (PPIs) are among the most frequently prescribed medications. Community-acquired pneumonia (CAP) is a common cause of morbidity, mortality and healthcare spending. Some studies suggest an increased risk of CAP among PPI users. We conducted a systematic review and meta-analysis to determine the association between outpatient PPI therapy and risk of CAP in adults. METHODS: We conducted systematic searches of MEDLINE, EMBASE, CINAHL, Cochrane Central Register of Controlled Trials, Scopus and Web of Science on February 3, 2014. Case-control studies, case-crossover, cohort studies and randomized controlled trials reporting outpatient PPI exposure and CAP diagnosis for patients ≥18 years old were eligible. Our primary outcome was the association between CAP and PPI therapy. A secondary outcome examined the risk of hospitalization for CAP and subgroup analyses evaluated the association between PPI use and CAP among patients of different age groups, by different PPI doses, and by different durations of PPI therapy. RESULTS: Systematic review of 33 studies was performed, of which 26 studies were included in the meta-analysis. These 26 studies included 226,769 cases of CAP among 6,351,656 participants. We observed a pooled risk of CAP with ambulatory PPI therapy of 1.49 (95% CI 1.16, 1.92; I2 99.2%). This risk was increased during the first month of therapy (OR 2.10; 95% CI 1.39, 3.16), regardless of PPI dose or patient age. PPI therapy also increased risk for hospitalization for CAP (OR 1.61; 95% CI: 1.12, 2.31). DISCUSSION: Outpatient PPI use is associated with a 1.5-fold increased risk of CAP, with the highest risk within the first 30 days after initiation of therapy. Providers should be aware of this risk when considering PPI use, especially in cases where alternative regimens may be available or the benefits of PPI use are uncertain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2014) · Medical Entomology and Zoology · Cited by 17,633
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205 · cited 1×
“that did not report a measure of association between PPI exposure and CAP but did include the required information, we calculated an unadjusted odds ratio using the Peto method [20].”
MethodThe case of the misleading funnel plot
Lau, J., Ioannidis, J. P. A., Terrin, N., Schmid, C. H., & Olkin, I. (2006) · BMJ · doi:10.1136/bmj.333.7568.597 · Cited by 1,766
A comparison of methods to detect publication bias in meta‐analysis
Macaskill, P., Walter, S. D., & Irwig, L. (2001) · Statistics in Medicine · doi:10.1002/sim.698 · Cited by 1,286 · cited 2×
“Though our funnel plot was limited by the number of included studies [56, 66], it suggested a publication bias toward a protective or null effect of PPI therapy.”
BackgroundRisk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive Drugs
Laheij, R. J. F. (2004) · JAMA · doi:10.1001/jama.292.16.1955 · Cited by 877
Kahrilas, P. J., Shaheen, N. J., & Vaezi, M. F. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.045 · Cited by 702
IMS Institute for Healthcare Informatics
Evans, R. (2014) · Nursing Standard · doi:10.7748/ns2014.04.28.32.30.s36 · Cited by 594
Anglemyer, A., Horvath, H. T., & Bero, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000034.pub2 · Cited by 534
Shrier, I., Boivin, J.-F., Steele, R. J., Platt, R. W., Furlan, A., Kakuma, R., Brophy, J., & Rossignol, M. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm189 · Cited by 493
Burden of Community-Acquired Pneumonia in North American Adults
File, T. M., & Marrie, T. J. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.03.2130 · Cited by 472
Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis
Eom, C.-S., Jeon, C. Y., Lim, J.-W., Cho, E.-G., Park, S. M., & Lee, K.-S. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.092129 · Cited by 393
Efficacy of Esomeprazole for Treatment of Poorly Controlled Asthma
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806290 · Cited by 382
Pereira, C., & Castilho, E. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp016 · Cited by 375
New evidence of risk factors for community-acquired pneumonia: a population-based study
Almirall, J., Bolíbar, I., Serra-Prat, M., Roig, J., Hospital, I., Carandell, E., Agustí, M., Ayuso, P., Estela, A., Torres, A., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00095807 · Cited by 354
Gulmez, S. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.950 · Cited by 341
Proton-Pump Inhibitor Use and the Risk for Community-Acquired Pneumonia
Sarkar, M., Hennessy, S., & Yang, Y.-X. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-6-200809160-00005 · Cited by 301
Review article: proton pump inhibitors and bacterial overgrowth
WILLIAMS, C., & McCOLL, K. E. L. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02707.x · Cited by 221
Clinical Efficacy of Pneumococcal Vaccine in the Elderly
Koivula, I., Stén, M., Leinonen, M., & Mäkelä, P. H. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00149-6 · Cited by 217
Increased Risk of Pneumonia Among Patients With Inflammatory Bowel Disease
Long, M. D., Martin, C., Sandler, R. S., & Kappelman, M. D. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.406 · Cited by 210
Modifiable Risk Factors for Nursing Home-Acquired Pneumonia
Quagliarello, V., Ginter, S., Han, L., Van Ness, P., Allore, H., & Tinetti, M. (2005) · Clinical Infectious Diseases · doi:10.1086/426023 · Cited by 203
Progress in Cardiovascular Diseases
Birkenhäger, W. H., & Staessen, J. A. (2006) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.03.001 · Cited by 202
The natural history of community-acquired pneumonia in COPD patients: A population database analysis
Müllerova, H., Chigbo, C., Hagan, G. W., Woodhead, M. A., Miravitlles, M., Davis, K. J., & Wedzicha, J. A. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.04.008 · Cited by 197
Filion, K. B., Chateau, D., Targownik, L. E., Gershon, A., Durand, M., Tamim, H., Teare, G. F., Ravani, P., Ernst, P., Dormuth, C. R., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304738 · Cited by 183
Pierson, T. C., Kieffer, T. L., Ruff, C. T., Buck, C., Gange, S. J., & Siliciano, R. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.4138-4144.2002 · Cited by 180
Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting.
Heidelbaugh, J. J., Goldberg, K. L., & Inadomi, J. M. (2010) · PubMed · Cited by 179
Sanduleanu, S., Jonkers, D., De Bruine, A., Hameeteman, W., & Stockbrügger, R. W. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00888.x · Cited by 170
Overutilization of Proton Pump Inhibitors: A Review of Cost-Effectiveness and Risk in PPI
Heidelbaugh, J. J., Goldberg, K. L., & Inadomi, J. M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.49 · Cited by 165
Scheiman, J. M., Devereaux, P. J., Herlitz, J. D., Katelaris, P., Lanas, Á., van Zanten, S. V., Nauclér, E., & Svedberg, L.-E. (2011) · Heart · doi:10.1136/hrt.2010.217547 · Cited by 147
Who is using chronic acid suppression therapy and why?
Jacobson, B. C., Ferris, T. G. G., Shea, T. L., Mahlis, E. M., Lee, T. H.-Y., & Wang, T. C. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07186.x · Cited by 143
Effect of Pneumococcal Vaccination in Hospitalized Adults With Community-Acquired Pneumonia
Johnstone, J., Marrie, T. J., Eurich, D. T., & Majumdar, S. R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.18.1938 · Cited by 143
Giuliano, C. A., Wilhelm, S. M., & Kale-Pradhan, P. B. (2012) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.20 · Cited by 136
Statin treatment and reduced risk of pneumonia in patients with diabetes
van de Garde, E. M. W., Hak, E., Souverein, P. C., Hoes, A. W., van den Bosch, J. M. M., & Leufkens, H. G. M. (2006) · Thorax · doi:10.1136/thx.2006.062885 · Cited by 132
Pasina, L., Nobili, A., Tettamanti, M., Salerno, F., Corrao, S., Marengoni, A., Iorio, A., Marcucci, M., & Mannucci, P. M. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.11.009 · Cited by 103
Myles, P. R., Hubbard, R., McKeever, T. M., et al. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1715 · Cited by 100
Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?
Fohl, A. L. (2011) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v2.i3.17 · Cited by 88
Yu, H., Rubin, J. L., Dunning, S. C., Li, S., & Sato, R. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04208.x · Cited by 81
Pharmacotherapy and the risk for community-acquired pneumonia
Gau, J., Acharya, U. H., Khan, S. A., Heh, V., Mody, L., & Kao, T.-C. (2010) · BMC Geriatrics · doi:10.1186/1471-2318-10-45 · Cited by 79
Juthani‐Mehta, M., de Rekeneire, N., Allore, H. G., Chen, S., O’Leary, J. R., Bauer, D. C., Harris, T. B., Newman, A. B., Yende, S. P., Weyant, R. J., et al. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12325 · Cited by 74
Dublin, S., Walker, R. L., Jackson, M. L., Nelson, J. C., Weiss, N. S., & Jackson, L. A. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1978 · Cited by 72
Acid-suppressive Drugs and Community-acquired Pneumonia
Rodríguez, L. A. G., Ruigómez, A., Wallander, M.-A. A., & Johansson, S. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181b5f27d · Cited by 71
Treatment patterns and symptom control in patients with GERD: US community-based survey
Chey, W. D., Mody, R., Wu, E. Q., Chen, L., Kothari, S., Persson, B., Beaulieu, N., & Lü, M. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903035745 · Cited by 71
Gastric acid‐suppressive therapy and community‐acquired respiratory infections
Laheij, R. J. F., van IJzendoorn, M. C., Janssen, M. J. R., & Jansen, J. B. �. �. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01744.x · Cited by 69
Jena, A. B., Sun, E. C., & Goldman, D. P. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2211-5 · Cited by 65
Hermos, J. A., Young, M., Fonda, J. R., GAGNON, D. R., Fiore, L. D., & Lawler, E. V. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir767 · Cited by 61
Nielsen, A., Nielsen, R. B., Riis, A. H., Johnsen, S. P., Sørensen, H. T., & Thomsen, R. W. (2012) · Critical Care · doi:10.1186/cc11418 · Cited by 60
BACTERIAL CHANGES IN THE SMALL INTESTINE IN MALABSORPTIVE STATES AND IN PERNICIOUS ANAEMIA.
Aw, D., & Rh, G. (1964) · PubMed · Cited by 55
Borriello, S. P., Reed, P. J., Dolby, J. M., Barclay, F. E., & WEBSTER, A. D. B. (1985) · Journal of Clinical Pathology · doi:10.1136/jcp.38.8.946 · Cited by 46
Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population
van de Garde, E. M. W., Souverein, P. C., van den Bosch, J. M. M., Deneer, V. H. M., & Leufkens, H. G. M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00110005 · Cited by 41
Proton‐pump inhibitors and the risk of antibiotic use and hospitalisation for pneumonia
Roughead, E. E., Ramsay, E. N., Pratt, N. L., et al. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02307.x · Cited by 35
Liu, C., Shau, W., Wu, C., & Lai, M. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328357a87a · Cited by 35
van de Garde, E. M. W., Souverein, P. C., Hak, E., Deneer, V. H. M., van den Bosch, J. M., & Leufkens, H. G. M. (2006) · Journal of Hypertension · doi:10.1097/hjh.0b013e328010520a · Cited by 33
Human Lung Mucous Glands Manifest Evidence of the H + /K + -ATPase Proton Pump
Altman, K. W., Waltonen, J. D., Tarján, G., et al. (2007) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348940711600311 · Cited by 31
Ramsay, E. N., Pratt, N. L., Ryan, P., & Roughead, E. E. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-82 · Cited by 30
Chen, C., Lin, H., Lin, H., et al. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.10.004 · Cited by 19
Rouse, G., Hardinger, K. L., Tsapepas, D. S., & Tichy, E. M. (2016) · Progress in Transplantation · doi:10.1177/1526924816669725 · Cited by 9
Pramipexole use and the risk of pneumonia
Ernst, P., Renoux, C., Dell’Aniello, S., & Suissa, S. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-113 · Cited by 6
Cited by
Martinez, F. J., Collard, H. R., Pardo, A., Raghu, G., Richeldi, L., Selman, M., Swigris, J. J., Taniguchi, H., & Wells, A. U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.74 · Cited by 1,388
Birnkrant, D. J., Bushby, K., Bann, C. M., Apkon, S. D., Blackwell, A., Brumbaugh, D., Case, L. E., Clemens, P. R., Hadjiyannakis, S., Pandya, S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30024-3 · Cited by 1,370
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease
Katz, P. O., Dunbar, K. B., Schnoll-Sussman, F. H., Greer, K. B., Yadlapati, R., & Spechler, S. J. (2022) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001538 · Cited by 1,038
Freedberg, D. E., Kim, L. S., & Yang, Y.-X. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.031 · Cited by 891
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
Lazarus, B., Chen, Y., Wilson, F. P., Sang, Y., Chang, A. R., Coresh, J., & Grams, M. E. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7193 · Cited by 729
Metadata
- Authors
- Lambert, A. A., Lam, J. O., Paik, J. J., Ugarte-Gil, C., Drummond, M. B., & Crowell, T. A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-06-04
- Volume
- 10
- Issue
- 6
- Pages
- e0128004
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W605005794
- Cited by
- 327
- References
- 62
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.